News archives

Click on a news to open it

March 2021 – Innosuisse support

GliaPharm receives support from Innosuisse for a project to develop specific cell therapy to treat neurological diseases in collaboration with Universities of Bern and Lausanne.

January 2021 – HEPIA collaboration

GliaPharm receives grant for collaboration with HEPIA to setup a new 3D culture method using brain organoids from mouse and human-derived cells.

September 2020 – European Congress of Neuropsychopharmacology

GliaPharm to present at the European Congress of Neuropsychopharmacology – Symposium on “Beyond the Neurocentric Paradigm: Targeting Astrocytes and Neuroglial Interactions in CNS Disorders”. September 13th 2020.

August 2020 – #FOXG1

GliaPharm to present at the virtual #FOXG1ScienceSymposium on August 17/18. Register here to tune in to hear from all the researchers, industry and more about the path to a cure for #FOXG1. #FOXG1SS2020

August 2020 – LifeSci Symposium

GliaPharm presented at the LifeSci Partners Summer Symposium on August 5th 2020

May 2020 – CHF 2 Million financing

GliaPharm completes a CHF 2 Million financing to advance its drug development program for an orphan neurological disease

January 2019 – Collaboration TRB

GliaPharm announces research collaboration with TRB Chemedica International

January 2019 – BLACKSWAN

GliaPharm receives support from the FOXG1 Research Foundation and the BLACKSWAN Foundation to uncover the metabolic effect of FOXG1 in astrocytes

January 2019 – #HTChallenge!

We made it to the @hellotmrc Global Finals of #HTChallenge! From 4,500 applications we have been named one of the 7 Industrial Biotech track Finalists competing to win at the #HTSummit! Come hear us pitch in Paris on March 14-15.

September 2017 – Cydan Award of the MassChallenge

GliaPharm receives the Cydan Award of the MassChallenge startup Accelerator program in Boston, 2017

May 2017 – Finalist to the MassChallenge

GliaPharm has been selected as a Finalist to the MassChallenge Switzerland 2017 startup contest

May 2017 – Campus Biotech

Une troisieme “start-up” rejoint le Campus Biotech

Article in 24heures and Tribune de Geneve (in French)

January 2017 – laboratory at the Campus Biotech

GliaPharm establishes its laboratory at the Campus Biotech in Geneva, Switzerland

September 2016 -Innosuisse

GliaPharm enters the start-up coaching program of Innosuisse (formerly CTI)

July 2016 – CTI financial

The Swiss Commission for Technology and Innovation (CTI) has granted financial support to the collaboration between GliaPharm and Prof. Magistretti’s laboratory (EPFL)

June 2016 – support from the Foundation Rita Puccini

GliaPharm receives financial support from the Foundation Rita Puccini pour l’Etude de la Sclérose Latérale Amyotrophique